Cornerstone’s Hyponatremia Therapy Lixivaptan Will Get Advisory Panel Scrutiny
This article was originally published in The Pink Sheet Daily
Executive Summary
The hyponatremia drug is a selective vasopressin V2-receptor antagonist, like Astellas’ Vaprisol and Otsuka’s Samsca.